Share Price and Basic Stock Data
Last Updated: February 12, 2026, 9:18 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Rajshree Sugars & Chemicals Ltd, operating in the sugar industry, reported a market capitalization of ₹104 Cr and a share price of ₹31.4. The company has experienced fluctuations in its revenue, with sales recorded at ₹767 Cr for the fiscal year ending March 2023, slightly declining to ₹764 Cr in March 2024 and further projected at ₹642 Cr for March 2025. Quarterly sales figures showed a peak of ₹240.12 Cr in June 2024, demonstrating some recovery from a low of ₹139.04 Cr in December 2022. The trailing twelve months (TTM) sales stood at ₹513 Cr, indicating a downward trend compared to previous fiscal years. The operating profit margin, which stood at 1.40% for the latest reporting period, reflects challenges in cost management and pricing strategies, particularly as the sugar sector often faces volatility in input costs and pricing pressures.
Profitability and Efficiency Metrics
Profitability metrics for Rajshree Sugars indicate significant challenges, with a reported net profit of ₹-30 Cr for the latest fiscal year. The operating profit margin fluctuated notably, with highs of 27.55% in March 2023, falling to 1.40% in September 2025. This inconsistency highlights the company’s struggle to maintain profitability amidst rising operational costs. The return on equity (ROE) stood at a mere 3.05%, while the return on capital employed (ROCE) was slightly better at 4.42%. These figures are considerably below industry averages, where sugar companies often target ROE levels above 10% to signify healthy returns. Furthermore, the interest coverage ratio (ICR) stood at 0.60x, indicating difficulties in meeting interest obligations, which raises concerns about financial sustainability.
Balance Sheet Strength and Financial Ratios
Rajshree Sugars’ balance sheet reveals a total borrowing of ₹335 Cr against reserves of ₹210 Cr, indicating a leveraged position that may pose risks in adverse market conditions. The company reported a price-to-book value (P/BV) of 0.65x, suggesting undervaluation compared to its book value, which may attract value investors. However, the current ratio of 0.61x and quick ratio of 0.20x signal potential liquidity issues, as they fall below the ideal benchmark of 1.0x for healthy liquidity. The company’s total liabilities stood at ₹651 Cr against total assets of ₹687 Cr, reflecting a precarious balance between debt and equity. Additionally, the cash conversion cycle of 34 days is relatively efficient, yet the overall financial health remains under scrutiny due to the high debt levels and declining profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Rajshree Sugars shows a stable promoter holding of 40.71%, while foreign institutional investors (FIIs) remain minimal at 0.04%. Domestic institutional investors (DIIs) account for 2.88%, indicating limited institutional confidence in the company’s prospects. The public holding constitutes 56.36%, reflecting a broad base of retail investors. The number of shareholders has increased to 32,427, suggesting growing interest in the stock despite the company’s financial challenges. The relatively low institutional ownership might hinder the company’s ability to attract significant capital for expansion or operational improvements. Investor confidence appears shaky, primarily due to the company’s persistent losses and uncertain profitability outlook, which could impact future stock performance.
Outlook, Risks, and Final Insight
Looking ahead, Rajshree Sugars faces both opportunities and risks. The sugar industry is poised for potential growth, driven by increasing domestic demand and supportive government policies. However, the company must navigate significant risks, including fluctuating sugar prices, rising input costs, and tightening margins. Operational efficiency improvements and strategic cost management will be crucial for enhancing profitability. Strengths include a solid market presence and potential for improved operational efficiencies, which could lead to better financial performance. Conversely, high debt levels and inconsistent profitability pose substantial risks. If Rajshree Sugars can stabilize its operations and leverage market opportunities effectively, it may turn its fortunes around. Otherwise, continued financial distress could lead to further declines in investor confidence and market valuation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 74.2 Cr. | 9.98 | 16.7/7.02 | 16.8 | 0.00 % | 36.6 % | % | 10.0 | |
| Dhampure Speciality Sugars Ltd | 92.5 Cr. | 106 | 115/82.0 | 17.6 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 668 Cr. | 100 | 115/57.3 | 28.2 | 145 | 1.24 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 514 Cr. | 39.3 | 63.1/36.0 | 8.43 | 105 | 5.09 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 646 Cr. | 4.50 | 10.3/3.03 | 76.1 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,799.62 Cr | 254.59 | 21.23 | 225.56 | 0.84% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 185.05 | 139.04 | 218.01 | 227.92 | 212.98 | 136.73 | 186.01 | 240.12 | 145.97 | 81.19 | 174.54 | 140.93 | 116.83 |
| Expenses | 178.63 | 152.38 | 157.95 | 210.20 | 185.25 | 154.76 | 157.73 | 223.72 | 135.45 | 98.28 | 145.63 | 146.12 | 115.20 |
| Operating Profit | 6.42 | -13.34 | 60.06 | 17.72 | 27.73 | -18.03 | 28.28 | 16.40 | 10.52 | -17.09 | 28.91 | -5.19 | 1.63 |
| OPM % | 3.47% | -9.59% | 27.55% | 7.77% | 13.02% | -13.19% | 15.20% | 6.83% | 7.21% | -21.05% | 16.56% | -3.68% | 1.40% |
| Other Income | 2.19 | 2.74 | 1.60 | 1.00 | 0.85 | 0.37 | 10.52 | 0.23 | 4.25 | 6.33 | 0.95 | 0.09 | 0.55 |
| Interest | 2.19 | 4.45 | 2.66 | 4.33 | 5.46 | 4.14 | 9.79 | 4.90 | -1.81 | 3.80 | 9.08 | 3.19 | 3.39 |
| Depreciation | 6.19 | 6.14 | 5.90 | 5.86 | 5.94 | 5.96 | 5.90 | 5.79 | 5.85 | 5.88 | 5.94 | 5.85 | 5.97 |
| Profit before tax | 0.23 | -21.19 | 53.10 | 8.53 | 17.18 | -27.76 | 23.11 | 5.94 | 10.73 | -20.44 | 14.84 | -14.14 | -7.18 |
| Tax % | 0.00% | 0.00% | 55.93% | 0.00% | 0.00% | 0.00% | 31.59% | 0.00% | 0.00% | 0.00% | 20.08% | 0.00% | 0.00% |
| Net Profit | 0.24 | -21.19 | 23.40 | 8.53 | 17.18 | -27.75 | 15.80 | 5.94 | 10.73 | -20.44 | 11.86 | -14.14 | -7.18 |
| EPS in Rs | 0.07 | -6.39 | 7.06 | 2.57 | 5.18 | -8.37 | 4.77 | 1.79 | 3.24 | -6.17 | 3.58 | -4.27 | -2.17 |
Last Updated: December 29, 2025, 10:30 am
Below is a detailed analysis of the quarterly data for Rajshree Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 116.83 Cr.. The value appears to be declining and may need further review. It has decreased from 140.93 Cr. (Jun 2025) to 116.83 Cr., marking a decrease of 24.10 Cr..
- For Expenses, as of Sep 2025, the value is 115.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 146.12 Cr. (Jun 2025) to 115.20 Cr., marking a decrease of 30.92 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.63 Cr.. The value appears strong and on an upward trend. It has increased from -5.19 Cr. (Jun 2025) to 1.63 Cr., marking an increase of 6.82 Cr..
- For OPM %, as of Sep 2025, the value is 1.40%. The value appears strong and on an upward trend. It has increased from -3.68% (Jun 2025) to 1.40%, marking an increase of 5.08%.
- For Other Income, as of Sep 2025, the value is 0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Jun 2025) to 0.55 Cr., marking an increase of 0.46 Cr..
- For Interest, as of Sep 2025, the value is 3.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.19 Cr. (Jun 2025) to 3.39 Cr., marking an increase of 0.20 Cr..
- For Depreciation, as of Sep 2025, the value is 5.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.85 Cr. (Jun 2025) to 5.97 Cr., marking an increase of 0.12 Cr..
- For Profit before tax, as of Sep 2025, the value is -7.18 Cr.. The value appears strong and on an upward trend. It has increased from -14.14 Cr. (Jun 2025) to -7.18 Cr., marking an increase of 6.96 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -7.18 Cr.. The value appears strong and on an upward trend. It has increased from -14.14 Cr. (Jun 2025) to -7.18 Cr., marking an increase of 6.96 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.17. The value appears strong and on an upward trend. It has increased from -4.27 (Jun 2025) to -2.17, marking an increase of 2.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 830 | 574 | 570 | 667 | 552 | 399 | 327 | 364 | 468 | 767 | 764 | 642 | 513 |
| Expenses | 766 | 566 | 532 | 526 | 518 | 385 | 319 | 336 | 436 | 715 | 708 | 603 | 505 |
| Operating Profit | 64 | 9 | 38 | 141 | 34 | 14 | 9 | 28 | 32 | 52 | 56 | 39 | 8 |
| OPM % | 8% | 1% | 7% | 21% | 6% | 4% | 3% | 8% | 7% | 7% | 7% | 6% | 2% |
| Other Income | 6 | 10 | 32 | 3 | 24 | 3 | 3 | 10 | 12 | 7 | 13 | 12 | 8 |
| Interest | 73 | 65 | 65 | 72 | 60 | 58 | 58 | 29 | 22 | 14 | 24 | 16 | 19 |
| Depreciation | 35 | 30 | 26 | 26 | 25 | 25 | 25 | 24 | 24 | 24 | 24 | 23 | 24 |
| Profit before tax | -39 | -76 | -21 | 46 | -27 | -65 | -70 | -16 | -3 | 21 | 21 | 11 | -27 |
| Tax % | -31% | -31% | -31% | 34% | -54% | -36% | -30% | 6% | 22% | 143% | 35% | 27% | |
| Net Profit | -27 | -53 | -14 | 30 | -13 | -42 | -49 | -17 | -3 | -9 | 14 | 8 | -30 |
| EPS in Rs | -11.21 | -22.18 | -5.74 | 10.67 | -4.47 | -14.85 | -17.52 | -5.95 | -0.96 | -2.71 | 4.15 | 2.44 | -9.03 |
| Dividend Payout % | 0% | 0% | 0% | 9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -96.30% | 73.58% | 314.29% | -143.33% | -223.08% | -16.67% | 65.31% | 82.35% | -200.00% | 255.56% | -42.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 169.88% | 240.70% | -457.62% | -79.74% | 206.41% | 81.97% | 17.05% | -282.35% | 455.56% | -298.41% |
Rajshree Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | -30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 17% |
| 3 Years: | 55% |
| TTM: | -207% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 26% |
| 3 Years: | 8% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | -1% |
| 3 Years: | 1% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 12:55 pm
Balance Sheet
Last Updated: December 4, 2025, 1:52 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 25 | 28 | 28 | 28 | 28 | 28 | 33 | 33 | 33 | 33 | 33 |
| Reserves | 81 | 24 | 12 | 116 | 103 | 62 | 11 | 2 | 228 | 218 | 232 | 231 | 210 |
| Borrowings | 654 | 675 | 691 | 615 | 458 | 403 | 358 | 432 | 427 | 401 | 393 | 299 | 335 |
| Other Liabilities | 270 | 145 | 145 | 330 | 170 | 250 | 283 | 213 | 249 | 170 | 148 | 123 | 72 |
| Total Liabilities | 1,029 | 867 | 873 | 1,089 | 760 | 743 | 680 | 676 | 938 | 822 | 806 | 687 | 651 |
| Fixed Assets | 544 | 513 | 489 | 551 | 528 | 505 | 483 | 427 | 612 | 589 | 569 | 524 | 516 |
| CWIP | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Investments | 55 | 67 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 427 | 285 | 315 | 537 | 230 | 236 | 196 | 248 | 325 | 232 | 236 | 161 | 133 |
| Total Assets | 1,029 | 867 | 873 | 1,089 | 760 | 743 | 680 | 676 | 938 | 822 | 806 | 687 | 651 |
Below is a detailed analysis of the balance sheet data for Rajshree Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
- For Reserves, as of Sep 2025, the value is 210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 231.00 Cr. (Mar 2025) to 210.00 Cr., marking a decrease of 21.00 Cr..
- For Borrowings, as of Sep 2025, the value is 335.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 299.00 Cr. (Mar 2025) to 335.00 Cr., marking an increase of 36.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 72.00 Cr.. The value appears to be improving (decreasing). It has decreased from 123.00 Cr. (Mar 2025) to 72.00 Cr., marking a decrease of 51.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 651.00 Cr.. The value appears to be improving (decreasing). It has decreased from 687.00 Cr. (Mar 2025) to 651.00 Cr., marking a decrease of 36.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 524.00 Cr. (Mar 2025) to 516.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 133.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2025) to 133.00 Cr., marking a decrease of 28.00 Cr..
- For Total Assets, as of Sep 2025, the value is 651.00 Cr.. The value appears to be declining and may need further review. It has decreased from 687.00 Cr. (Mar 2025) to 651.00 Cr., marking a decrease of 36.00 Cr..
However, the Borrowings (335.00 Cr.) are higher than the Reserves (210.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -590.00 | -666.00 | -653.00 | -474.00 | -424.00 | -389.00 | -349.00 | -404.00 | -395.00 | -349.00 | -337.00 | -260.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 14 | 22 | 35 | 31 | 31 | 57 | 48 | 31 | 24 | 19 | 15 | 14 |
| Inventory Days | 145 | 160 | 192 | 285 | 129 | 144 | 109 | 175 | 196 | 96 | 113 | 90 |
| Days Payable | 88 | 93 | 92 | 157 | 118 | 218 | 222 | 208 | 180 | 87 | 78 | 70 |
| Cash Conversion Cycle | 71 | 89 | 135 | 159 | 42 | -17 | -64 | -1 | 40 | 27 | 50 | 34 |
| Working Capital Days | -26 | -41 | -66 | -65 | -89 | -227 | -414 | -63 | -16 | 7 | -6 | 3 |
| ROCE % | 5% | -2% | 2% | 16% | 2% | -1% | -3% | 2% | 3% | 5% | 7% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 9.42 | 10.56 | -5.98 | -27.61 | -14.44 |
| Diluted EPS (Rs.) | 9.42 | 10.56 | -5.09 | -27.61 | -14.44 |
| Cash EPS (Rs.) | 18.40 | 19.74 | 3.50 | -14.23 | 1.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.73 | 37.20 | -0.69 | 5.99 | 35.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.73 | 37.20 | -0.69 | 5.99 | 35.39 |
| Revenue From Operations / Share (Rs.) | 196.07 | 236.66 | 285.49 | 298.69 | 388.12 |
| PBDIT / Share (Rs.) | 12.89 | 51.13 | 17.62 | 3.86 | 28.34 |
| PBIT / Share (Rs.) | 3.91 | 41.85 | 6.39 | -9.52 | 12.18 |
| PBT / Share (Rs.) | -17.42 | 16.28 | -11.19 | -39.83 | -20.90 |
| Net Profit / Share (Rs.) | 9.42 | 10.46 | -7.73 | -27.61 | -14.44 |
| NP After MI And SOA / Share (Rs.) | 9.42 | 10.46 | -7.73 | -27.61 | -14.44 |
| PBDIT Margin (%) | 6.57 | 21.60 | 6.17 | 1.29 | 7.30 |
| PBIT Margin (%) | 1.99 | 17.68 | 2.23 | -3.18 | 3.13 |
| PBT Margin (%) | -8.88 | 6.88 | -3.91 | -13.33 | -5.38 |
| Net Profit Margin (%) | 4.80 | 4.42 | -2.70 | -9.24 | -3.72 |
| NP After MI And SOA Margin (%) | 4.80 | 4.42 | -2.70 | -9.24 | -3.72 |
| Return on Networth / Equity (%) | 20.15 | 28.12 | 0.00 | -460.75 | -40.80 |
| Return on Capital Employeed (%) | 2.64 | 25.45 | 3.62 | -4.55 | 4.58 |
| Return On Assets (%) | 3.49 | 2.64 | -2.05 | -6.85 | -3.08 |
| Long Term Debt / Equity (X) | 2.16 | 3.36 | -258.45 | 33.96 | 6.17 |
| Total Debt / Equity (X) | 2.79 | 4.73 | -374.08 | 46.25 | 8.16 |
| Asset Turnover Ratio (%) | 0.58 | 0.65 | 0.62 | 0.57 | 0.79 |
| Current Ratio (X) | 0.61 | 0.84 | 0.73 | 0.78 | 1.00 |
| Quick Ratio (X) | 0.20 | 0.36 | 0.18 | 0.16 | 0.32 |
| Inventory Turnover Ratio (X) | 1.05 | 1.61 | 1.72 | 1.50 | 2.36 |
| Interest Coverage Ratio (X) | 0.60 | 2.00 | 0.61 | 0.12 | 0.85 |
| Interest Coverage Ratio (Post Tax) (X) | 0.42 | 1.42 | 0.34 | 0.08 | 0.56 |
| Enterprise Value (Cr.) | 451.53 | 614.15 | 745.71 | 699.22 | 658.60 |
| EV / Net Operating Revenue (X) | 0.81 | 0.92 | 1.05 | 0.98 | 0.71 |
| EV / EBITDA (X) | 12.43 | 4.26 | 16.95 | 76.15 | 9.77 |
| MarketCap / Net Operating Revenue (X) | 0.15 | 0.26 | 0.13 | 0.06 | 0.06 |
| Price / BV (X) | 0.65 | 1.67 | -55.23 | 3.18 | 0.74 |
| Price / Net Operating Revenue (X) | 0.15 | 0.26 | 0.13 | 0.06 | 0.06 |
| EarningsYield | 0.30 | 0.16 | -0.20 | -1.45 | -0.54 |
After reviewing the key financial ratios for Rajshree Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.56 (Mar 17) to 9.42, marking a decrease of 1.14.
- For Diluted EPS (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.56 (Mar 17) to 9.42, marking a decrease of 1.14.
- For Cash EPS (Rs.), as of Mar 18, the value is 18.40. This value is within the healthy range. It has decreased from 19.74 (Mar 17) to 18.40, marking a decrease of 1.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 46.73. It has increased from 37.20 (Mar 17) to 46.73, marking an increase of 9.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 46.73. It has increased from 37.20 (Mar 17) to 46.73, marking an increase of 9.53.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 196.07. It has decreased from 236.66 (Mar 17) to 196.07, marking a decrease of 40.59.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 12.89. This value is within the healthy range. It has decreased from 51.13 (Mar 17) to 12.89, marking a decrease of 38.24.
- For PBIT / Share (Rs.), as of Mar 18, the value is 3.91. This value is within the healthy range. It has decreased from 41.85 (Mar 17) to 3.91, marking a decrease of 37.94.
- For PBT / Share (Rs.), as of Mar 18, the value is -17.42. This value is below the healthy minimum of 0. It has decreased from 16.28 (Mar 17) to -17.42, marking a decrease of 33.70.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.46 (Mar 17) to 9.42, marking a decrease of 1.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.46 (Mar 17) to 9.42, marking a decrease of 1.04.
- For PBDIT Margin (%), as of Mar 18, the value is 6.57. This value is below the healthy minimum of 10. It has decreased from 21.60 (Mar 17) to 6.57, marking a decrease of 15.03.
- For PBIT Margin (%), as of Mar 18, the value is 1.99. This value is below the healthy minimum of 10. It has decreased from 17.68 (Mar 17) to 1.99, marking a decrease of 15.69.
- For PBT Margin (%), as of Mar 18, the value is -8.88. This value is below the healthy minimum of 10. It has decreased from 6.88 (Mar 17) to -8.88, marking a decrease of 15.76.
- For Net Profit Margin (%), as of Mar 18, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.42 (Mar 17) to 4.80, marking an increase of 0.38.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 4.80. This value is below the healthy minimum of 8. It has increased from 4.42 (Mar 17) to 4.80, marking an increase of 0.38.
- For Return on Networth / Equity (%), as of Mar 18, the value is 20.15. This value is within the healthy range. It has decreased from 28.12 (Mar 17) to 20.15, marking a decrease of 7.97.
- For Return on Capital Employeed (%), as of Mar 18, the value is 2.64. This value is below the healthy minimum of 10. It has decreased from 25.45 (Mar 17) to 2.64, marking a decrease of 22.81.
- For Return On Assets (%), as of Mar 18, the value is 3.49. This value is below the healthy minimum of 5. It has increased from 2.64 (Mar 17) to 3.49, marking an increase of 0.85.
- For Long Term Debt / Equity (X), as of Mar 18, the value is 2.16. This value exceeds the healthy maximum of 1. It has decreased from 3.36 (Mar 17) to 2.16, marking a decrease of 1.20.
- For Total Debt / Equity (X), as of Mar 18, the value is 2.79. This value exceeds the healthy maximum of 1. It has decreased from 4.73 (Mar 17) to 2.79, marking a decrease of 1.94.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.58. It has decreased from 0.65 (Mar 17) to 0.58, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 18, the value is 0.61. This value is below the healthy minimum of 1.5. It has decreased from 0.84 (Mar 17) to 0.61, marking a decrease of 0.23.
- For Quick Ratio (X), as of Mar 18, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 17) to 0.20, marking a decrease of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 1.05. This value is below the healthy minimum of 4. It has decreased from 1.61 (Mar 17) to 1.05, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 0.60. This value is below the healthy minimum of 3. It has decreased from 2.00 (Mar 17) to 0.60, marking a decrease of 1.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 0.42. This value is below the healthy minimum of 3. It has decreased from 1.42 (Mar 17) to 0.42, marking a decrease of 1.00.
- For Enterprise Value (Cr.), as of Mar 18, the value is 451.53. It has decreased from 614.15 (Mar 17) to 451.53, marking a decrease of 162.62.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 17) to 0.81, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 18, the value is 12.43. This value is within the healthy range. It has increased from 4.26 (Mar 17) to 12.43, marking an increase of 8.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 17) to 0.15, marking a decrease of 0.11.
- For Price / BV (X), as of Mar 18, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 1.67 (Mar 17) to 0.65, marking a decrease of 1.02.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 17) to 0.15, marking a decrease of 0.11.
- For EarningsYield, as of Mar 18, the value is 0.30. This value is below the healthy minimum of 5. It has increased from 0.16 (Mar 17) to 0.30, marking an increase of 0.14.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rajshree Sugars & Chemicals Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.64% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.15% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.2
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 21.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.79
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | The Uffizi, Coimbatore Tamil Nadu 641004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Rajshree Pathy | Chairperson |
| Mr. R Varadarajan | Whole Time Director |
| Mr. K Ilango | Independent Director |
| Mr. Sheilendra Bhansali | Independent Director |
| Mr. S Vasudevan | Independent Director |
| Mr. S Krishnaswami | Independent Director |
FAQ
What is the intrinsic value of Rajshree Sugars & Chemicals Ltd?
Rajshree Sugars & Chemicals Ltd's intrinsic value (as of 12 February 2026) is ₹17.60 which is 39.93% lower the current market price of ₹29.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹97.2 Cr. market cap, FY2025-2026 high/low of ₹53.0/28.8, reserves of ₹210 Cr, and liabilities of ₹651 Cr.
What is the Market Cap of Rajshree Sugars & Chemicals Ltd?
The Market Cap of Rajshree Sugars & Chemicals Ltd is 97.2 Cr..
What is the current Stock Price of Rajshree Sugars & Chemicals Ltd as on 12 February 2026?
The current stock price of Rajshree Sugars & Chemicals Ltd as on 12 February 2026 is ₹29.3.
What is the High / Low of Rajshree Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rajshree Sugars & Chemicals Ltd stocks is ₹53.0/28.8.
What is the Stock P/E of Rajshree Sugars & Chemicals Ltd?
The Stock P/E of Rajshree Sugars & Chemicals Ltd is .
What is the Book Value of Rajshree Sugars & Chemicals Ltd?
The Book Value of Rajshree Sugars & Chemicals Ltd is 73.3.
What is the Dividend Yield of Rajshree Sugars & Chemicals Ltd?
The Dividend Yield of Rajshree Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Rajshree Sugars & Chemicals Ltd?
The ROCE of Rajshree Sugars & Chemicals Ltd is 4.42 %.
What is the ROE of Rajshree Sugars & Chemicals Ltd?
The ROE of Rajshree Sugars & Chemicals Ltd is 3.05 %.
What is the Face Value of Rajshree Sugars & Chemicals Ltd?
The Face Value of Rajshree Sugars & Chemicals Ltd is 10.0.